Quantification of Anterior Chamber Particles Using Anterior Segment Optical Coherence Tomography in Angle-Closure Glaucoma Patients after Laser Iridotomy.
anterior chamber
anterior segment optical coherence tomography
laser iridotomy
objective quantification
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
28 Jul 2022
28 Jul 2022
Historique:
received:
17
05
2022
revised:
11
06
2022
accepted:
26
07
2022
entrez:
12
8
2022
pubmed:
13
8
2022
medline:
13
8
2022
Statut:
epublish
Résumé
Purpose: To determine whether the degree of particle density in the anterior chamber can be evaluated objectively and quantitatively by anterior segment optical coherence tomography (AS-OCT) in cases after laser iridotomy (LI). Methods: This was a retrospective observational study. All of the subjects who received LI for angle-closure glaucoma between January 2018 and May 2019 at Kagoshima University Hospital were studied. AS-OCT recordings were made before, immediately after, and one week after LI in 22 eyes of 14 consecutive patients. The anterior chamber particle (ACP) index was defined as the ratio of the number of particles in the anterior chamber to the total area of the anterior chamber. The ACP index was determined by binarization of the AS-OCT images and analysis with the ImageJ program. Results: The mean age of the participants was 75.4 ± 8.9 years, with a range of 61−91 years. The ACP index before the LI was 0.78 ± 0.68, and it was significantly increased to 7.72 ± 2.64 immediately after the LI (paired t-test, p < 0.01). The ACP index returned to the pre-LI density of 0.92 ± 0.48 one week after the LI. Conclusions: We successfully quantified the degree of anterior chamber particles accumulation by analyzing images obtained by AS-OCT. This simple and repeatable technique should be useful because the particles, including inflammatory cells, in the anterior chamber can be evaluated non-invasively and objectively.
Identifiants
pubmed: 35955996
pii: jcm11154379
doi: 10.3390/jcm11154379
pmc: PMC9369109
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Japan Society for the Promotion of Science
ID : KAKENHI 21H03095
Références
Am J Ophthalmol. 2005 Sep;140(3):509-16
pubmed: 16196117
Acta Ophthalmol. 2016 Mar;94(2):e135-41
pubmed: 26408205
Am J Ophthalmol. 2009 Mar;147(3):413-416.e3
pubmed: 19054493
Invest Ophthalmol Vis Sci. 2014 Jun 03;55(6):3893-9
pubmed: 24894395
Ophthalmology. 2007 Jul;114(7):1278-85
pubmed: 17307254
Invest Ophthalmol Vis Sci. 2013 Jan 09;54(1):258-65
pubmed: 23249705
Graefes Arch Clin Exp Ophthalmol. 2017 Sep;255(9):1697-1704
pubmed: 28616714
Ophthalmology. 2015 Jul;122(7):1464-70
pubmed: 25846846
Am J Ophthalmol. 2015 Jun;159(6):1123-1131.e1
pubmed: 25790737
Am J Ophthalmol. 2006 Jul;142(1):166-8
pubmed: 16815272
Int Ophthalmol. 2015 Oct;35(5):629-33
pubmed: 22855363
Arch Ophthalmol. 2006 Mar;124(3):387-93
pubmed: 16534059
Ophthalmology. 2008 Feb;115(2):292-297.e3
pubmed: 17669498
PLoS One. 2014 Jul 28;9(7):e103586
pubmed: 25068821
Ophthalmology. 2007 Jan;114(1):47-53
pubmed: 17070581
Am J Ophthalmol. 2020 Aug;216:59-68
pubmed: 32251654
Retina. 2016 Jan;36(1):181-7
pubmed: 26049621
Invest Ophthalmol Vis Sci. 2012 Feb 13;53(2):693-7
pubmed: 22222269